3-(9-acridinylamino)-5-hydroxymethylaniline-ethylcarbamate-O-glutaric acid monoester | 470480-98-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 3-(9-acridinylamino)-5-hydroxymethylaniline-ethylcarbamate-O-glutaric acid monoester
• 英文别名: 5-[[3-(Acridin-9-ylamino)-5-(ethoxycarbonylamino)phenyl]methoxy]-5-oxopentanoic acid
• CAS: 470480-98-9
• 化学式: C₂₈H₂₇N₃O₆
• 分子量: 501.539
• InChiKey: HKWGCHSTIBDHBS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.5
• 重原子数：
  37
• 可旋转键数：
  12
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.21
• 拓扑面积：
  127
• 氢给体数：
  3
• 氢受体数：
  8

反应信息

• 作为反应物：
  描述：

  4-amino-N-[5-[2-(dimethylamino)ethylcarbamoyl]-1-methylpyrrol-3-yl]-1-methylpyrrole-2-carboxamide 、 3-(9-acridinylamino)-5-hydroxymethylaniline-ethylcarbamate-O-glutaric acid monoester 在 benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate 、 N,N-二异丙基乙胺 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 14.0h， 以50.8%的产率得到N-[2-(dimethylamino)ethyl]-1-methyl-4-[1-methyl-4-[[[3-(9-acridinylamino)-5-(ethoxycarbonylamino)benzyloxy]carbonylbutanoyl]amino]pyrrole-2-carboxamido]pyrrole-2-carboxamide
  参考文献：
  名称：

  Antitumor AHMA Linked to DNA Minor Groove Binding Agents:  Synthesis and Biological Evaluation

  摘要：

  DNA minor groove binder hybrid molecules, netropsin derivatives such as N-[2-(dimethylamino)ethyl]-1-methyl-4-aminopyrrolo-2-carboxamide (MePy) or its derivatives containing two units of N-methylpyrrolecarboxamide (diMePy) and bisbenzimidazole (Ho33258), were linked to the NH2 function of AHMA or to the CH2OH group of AHMA-ethylcarbamate to form AHMA-N-netropsins (13-16) and AHMA-ethylcarbamate-O-netropsins (19-22), and AHMA-bis-benzimidazole (AHMA-Ho33258, 25), respectively. These conjugates' in vitro antitumor activity, inhibition of a variety of human tumor cell growth, revealed that AHMA-ethylcarbamate-O-netropsin derivatives were more cytotoxic than AHMA-N-netropsin compounds. In the same studies, all compounds bearing MePy were more potent than those compounds linked with diMePy. Moreover, AHMA-netropsin derivatives bearing a succinyl chain as the linking spacer were more potent than those compounds having a glutaryl bridge. Among these hybrid molecules, AHMA-ethylcarbamate-O-succinyl-MePy (19) was 2- to 6-fold more cytotoxic than the parent compound AHMA (5) in various cell lines, whereas compound 25 had very poor solubility and was inactive. Studies on the inhibitory effect against topoisomerase II (Topo II) and DNA interaction of these conjugates showed no correlation between the potency of DNA binding and inhibitory activity against Topo II.

  DOI：

  10.1021/jm0200714
• 作为产物：
  描述：

  戊二酸酐 、 [3-(acridin-9-ylamino)-5-hydroxymethylphenyl]carbamic acidethyl ester 在 吡啶 、 4-二甲氨基吡啶 作用下， 反应 12.0h， 以83%的产率得到3-(9-acridinylamino)-5-hydroxymethylaniline-ethylcarbamate-O-glutaric acid monoester
  参考文献：
  名称：

  Antitumor AHMA Linked to DNA Minor Groove Binding Agents:  Synthesis and Biological Evaluation

  摘要：

  DNA minor groove binder hybrid molecules, netropsin derivatives such as N-[2-(dimethylamino)ethyl]-1-methyl-4-aminopyrrolo-2-carboxamide (MePy) or its derivatives containing two units of N-methylpyrrolecarboxamide (diMePy) and bisbenzimidazole (Ho33258), were linked to the NH2 function of AHMA or to the CH2OH group of AHMA-ethylcarbamate to form AHMA-N-netropsins (13-16) and AHMA-ethylcarbamate-O-netropsins (19-22), and AHMA-bis-benzimidazole (AHMA-Ho33258, 25), respectively. These conjugates' in vitro antitumor activity, inhibition of a variety of human tumor cell growth, revealed that AHMA-ethylcarbamate-O-netropsin derivatives were more cytotoxic than AHMA-N-netropsin compounds. In the same studies, all compounds bearing MePy were more potent than those compounds linked with diMePy. Moreover, AHMA-netropsin derivatives bearing a succinyl chain as the linking spacer were more potent than those compounds having a glutaryl bridge. Among these hybrid molecules, AHMA-ethylcarbamate-O-succinyl-MePy (19) was 2- to 6-fold more cytotoxic than the parent compound AHMA (5) in various cell lines, whereas compound 25 had very poor solubility and was inactive. Studies on the inhibitory effect against topoisomerase II (Topo II) and DNA interaction of these conjugates showed no correlation between the potency of DNA binding and inhibitory activity against Topo II.

  DOI：

  10.1021/jm0200714